A new medical cannabis card initiative in the UK is designed to provide a legal argument for exemption from prosecution for possession of cannabis. It won't just be good for patients, but also police. While cannabis medicines became legal in the UK in 2018, many patients are unable to afford...

The U.S. Department of Agriculture (USDA) Risk Management Agency (RMA) has announced an expansion of the pilot Multi-Peril Crop Insurance (MPCI) plan for hemp that will take effect in the 2021 crop year. MCPI is the most common form of the federal crop insurance programme in the USA that insures...

Regulatory hurdles, backbreaking work and an uncertain market. Top that off with then having your crop destroyed and it was a really crappy season for some hemp farmers in the US state of Iowa. The Des Moines Register reported last week reported approximately 13% of Iowa farmers' hemp crops had...

There were hopes a (positive) TGA decision would be published last week in relation to over-the-counter cannabidiol (CBD) in Australia. Here's what's happening. First, a recap of the road to this point. Cannabidiol is a non-intoxicating (i.e., it doesn't create a high) cannabinoid that can be extracted from hemp. CBD has...

Australia's Cann Group Limited (ASX:CAN) announced on Wednesday the Office of Drug Control (ODC) has varied the licences necessary to enable activity at its Mildura medical cannabis facility. Originally to be a huge single stage project, Cann Group is developing its new medicinal cannabis production facilities near Mildura in Victoria...

A new study on the long-term effects of cannabidiol (CBD) on roundworms has been published. Here's why it has some significance. Canada's Canopy Growth announced recently announced its medical division, Spectrum Therapeutics, carried out a study focusing on toxicity and lifespan effects of CBD in Caenorhabditis elegans - roundworms. However,...

Tasmanian Greens MP Rosalie Woodruff has strongly criticised the State Government's medical cannabis Controlled Access Scheme. Introduced in 2017, the Scheme only enables medical specialists the ability to prescribe products to patients in circumstances where conventional treatments have failed. It's a seven-step process: Patient first needs to consult a...

The Court of Justice of the European Union has ruled member states must not prohibit the marketing of lawfully produced cannabidiol (CBD). The case in question was in relation to a situation where parties produced hemp-derived CBD in the Czech Republic that was then imported into France for use in...

Prescriptions for Bod Australia's (ASX:BDA) MediCabilis product saw a big jump in October according to the company. MediCabilis is CBD based formulation in oil and wafer form, accessible for clinical trial use and for patients in Australia through the Therapeutic Goods Administration (TGA) Approved Prescriber (AP) and Special Access Schemes...

Australian medicinal cannabis company Althea has received the tick of approval from German authorities for its products. In May this year, the company signed an agreement with Nimbus Health GmbH for Althea to supply its full range of medical cannabis products to Nimbus over a three year period. What's been...